BG
CPIX icon

BlackRock Group’s Cumberland Pharmaceuticals CPIX Stock Holding History

BlackRock Group’s Portfolio CPIX Stock Details CPIX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q4 		– Sell
-132,563
Closed -$601K – 2689
2013
Q3 		$601K Buy
+132,563
New +$660K ﹤0.01% 2152

Other funds holding CPIX

AI
Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
KIM
Kestrel Investment Management San Mateo, California $167M AUM 20.81% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $71.6B AUM 29.66% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GHA
GW Henssler & Associates Kennesaw, Georgia $2.12B AUM 20.77% 1-Year Est. Return
UCFA
United Capital Financial Advisors Irving, Texas $16.3B AUM 16.34% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
PCM
Perritt Capital Management Chicago, Illinois $59.8M AUM 26.94% 1-Year Est. Return

BlackRock Group's CPIX Position: Q4 2013 in Review

BlackRock Group sold out of Cumberland Pharmaceuticals (CPIX) in Q4 2013, closing a stake of 132,563 shares — an estimated $601K sold.

BlackRock Group first reported a position in CPIX in Q3 2013 and held it in 1 quarter. The position peaked at $601K in Q3 2013. 45 funds tracked by Wall St. Rank hold CPIX as of Q4 2013.

  • BlackRock Group reported no remaining Cumberland Pharmaceuticals position as of Q4 2013 after selling out during the quarter.
  • BlackRock Group sold 132,563 Cumberland Pharmaceuticals shares in Q4 2013, an estimated $601K.
  • BlackRock Group first reported a position in Cumberland Pharmaceuticals in Q3 2013 and held it in 1 quarter.
  • BlackRock Group's Cumberland Pharmaceuticals position peaked at $601K in Q3 2013.
  • 45 funds tracked by Wall St. Rank held Cumberland Pharmaceuticals as of Q4 2013.

Based on BlackRock Group's 13F filing for Q4 2013, filed 12 Feb 2014.